Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2007Cited by 2.3k
Patients' Expectations about Effects of Chemotherapy for Advanced CancerJane C. Weeks, Deborah Schrag, Paul J. Catalano et al.|New England Journal of Medicine|2012Cited by 1.1k
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2005Cited by 344
Mechanisms of morbidity and mortality from exposure to ambient air particles.John J. Godleski, Cheryl R. Killingsworth, Richard L. Verrier et al.|PubMed|2000Cited by 254
Large language models to identify social determinants of health in electronic health recordsMarco Guevara-Vega, Danielle S. Bitterman, Shan Chen et al.|npj Digital Medicine|2024Cited by 249